Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC

J M Cerqueiro-González1, Á González-Franco2, S Carrascosa-García3

  • 1Servicio de Medicina Interna, Hospital Universitario Lucus Augusti, Lugo, Spain.

Insights

A comprehensive continuous care program (UMIPIC program) significantly reduced hospital admissions and mortality in heart failure with preserved ejection fraction (HFpEF) patients. This approach offers a vital benefit for managing this high-risk population.

Area of Science:

  • Cardiology and Internal Medicine
  • Clinical Trial Research
  • Patient Management Strategies

Background:

  • Heart failure with preserved ejection fraction (HFpEF) affects older patients with multiple comorbidities.
  • HFpEF patients often lack effective therapeutic options and face high risks of hospitalization and mortality.
  • This study investigates the impact of a specialized care program on HFpEF outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of the comprehensive continuous care program (UMIPIC program) in patients with HFpEF.
  • To assess the program's impact on reducing hospital admissions and mortality rates.

Main Methods:

  • Prospective analysis of 2401 HFpEF patients from the RICA registry.
  • Comparison between the UMIPIC program group (n: 1011) and conventional care group (RICA, n: 1390).
  • Propensity score matching (753 patients per group) to ensure comparability; 12-month follow-up for admissions and mortality.

Main Results:

  • The UMIPIC group showed significantly lower HF admission rates (19.2% vs. 36.5%; HR=0.56) compared to the RICA group.
  • Mortality was substantially reduced in the UMIPIC group (12.6% vs. 28%; HR=0.40).
  • No significant difference in non-HF related hospitalizations was observed between the groups.

Conclusions:

  • The UMIPIC program, a comprehensive continuous care model, effectively reduces hospital admissions for HFpEF patients.
  • This program also significantly lowers mortality rates in HFpEF patients with high comorbidity.
  • Continuous care is a beneficial strategy for managing high-risk HFpEF populations.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
95
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
157